Search All News
New insights into genetic architecture of disease hold promise for improved risk prediction and novel drug design.
Columbia study finds rates are lowest among rural, Black, Hispanic, and Medicaid patients.
As more states legalize cannabis for medical or recreational purposes its use during pregnancy is increasing, along with the potential for abuse or dependence.
- November 2, 2021
Five-year Columbia clinical trial indicates rapid cognitive shift diminishes suicidal thoughts, independently of improvement in depressive symptoms
- September 21, 2021
Columbia Psychiatry's Caroline Arout uses quantitative sensory testing, or QST, for assessing the effectiveness of cannabis for therapeutic uses.
- August 10, 2021
A collaborative study from Columbia University and the Copenhagen Research Centre for Mental Health examines the relationship between Lyme disease and psychiatric outcomes.
- May 26, 2021
Columbia study also finds people with schizophrenia, overall, have a 4.5-fold increased risk of dying from suicide.
- May 24, 2021
A Columbia study looked at a short and promising approach that could encourage more health workers to get the mental health care they need via a method centered on a three-minute video.
Source:Medpage TodayFebruary 24, 2021
Dr. Jeffrey Lieberman and co-authors hypothesized that combining the xanomeline with trospium could lessen xanomeline's typical side effects in treating schizophrenia.
- February 18, 2021
Columbia researchers have published their first report on mass shootings from the Columbia Mass Murder Database (CMMD).